While the $69 billion merger between CVS Health and Aetna has been approved by regulators and cleared by the Department of Justice, a federal judge has raised the prospect of not approving the deal, CNBC reported.
A judge from the U.S. District Court for the District of Columbia noted the deal, which closed Nov. 28, was given a “rubber stamp” treatment by governments, according to CNBC. Despite being approved by other regulators, the agreement between the government and the two companies must also be approved by the court.
According to Aetna, the situation is “commonplace,” CNBC reported.
See the full story below: